<DOC>
	<DOCNO>NCT00383903</DOCNO>
	<brief_summary>The purpose study determine appropriate regimen GSK HRV vaccine concomitant administration EPI vaccines infant South Africa .</brief_summary>
	<brief_title>Evaluate Safety &amp; Immunogenicity 2 3 Doses GSK HRV Vaccine Healthy Infants South Africa</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant bear normal gestation period ( &gt; =36 week ) , 5 10 week age Dose 1 confirm negative HIV status subject 's mother . Written inform consent obtain parent/guardian subject study entry . History allergic disease/polio disease , Confirmed suspect immunosuppressive immunodeficient condition , Clinically significant history chronic gastrointestinal disease serious medical condition determine investigator , Received treatment prohibit protocol . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection .</criteria>
	<gender>All</gender>
	<minimum_age>5 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>